• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 11500A
Device Problems Perivalvular Leak (1457); Detachment of Device or Device Component (2907)
Patient Problem Insufficient Information (4580)
Event Date 03/22/2022
Event Type  Injury  
Manufacturer Narrative
The patient died while using a medical product, but there was no suspected association between the death and the use of the product.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
Through medical records, it was learned that patient was taken back to the or due to severe pvl leaks around the aortic valve.The valve was inspected and there were several areas of dehiscence.The valve was removed and replaced with a 25mm konnect valved conduit.Post bypass echo showed well seated and well-functioning prosthesis with acceptable gradients; however, the patient was profoundly vasoplegio and hypotensive.Shortly after separating from cpb, the rv ballooned out and failed and requiring re-institution of bypass.After 30 minutes of rest, the patient separated from cbp, but the rv again eventually dilated.The patient was placed on central ecmo.Even with full flow, the patient profound vasoplegia requiring maximal vasoactive support but with little effect.It was clear that this was an unsurvivable situation due to brain hypoperfusion and the patient expired.
 
Manufacturer Narrative
H11: corrected data: mfr #2015691-2022 -05071 is a duplicate report and was already submitted under mfr #2015691-2022-04555.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INSPIRIS RESILIA AORTIC VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
reginald santos
1 edwards way
mailstop ant 6.1
irvine, CA 92614
9492502731
MDR Report Key14108488
MDR Text Key289286579
Report Number2015691-2022-05071
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00690103194982
UDI-Public(01)00690103194982(17)250421(11)210422217742645
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number11500A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/22/2022
Initial Date FDA Received04/13/2022
Supplement Dates Manufacturer Received04/20/2022
Supplement Dates FDA Received04/20/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention; Hospitalization;
Patient Age44 YR
Patient SexMale
-
-